August 15, 2019
August 9, 2019
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused... Read More
August 9, 2019
Geneia AI-Based Model Improves Personalization and Precision of Health Risk Scores
Geneia, a healthcare analytic solutions and services company that is simplifying the evolution to value-based care, announced today that the Geneia Data Intelligence Lab... Read More
August 9, 2019
MolecularMatch Announces Issuance of US Patent for its Precision Medicine Service
MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced today that the United States Patent and Trademark Office has... Read More
August 6, 2019
Genomenon Wins NIH Grant to Develop Micropublications for Genomic Interpretation
Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small... Read More
August 2, 2019
Siemens Healthineers, University of Missouri System and University of Missouri Health Care announce formation of new strategic alliance
Siemens Healthineers and the University of Missouri System (UM System), including all four universities, and University of Missouri Health Care (MU Health Care), have... Read More
August 2, 2019
Massive Bio Launches A Hub to Assemble The Largest Artificial Intelligence Enabled Just-In-Time Precision Oncology Clinical Trial Network in The World
Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub”... Read More
August 2, 2019
Sema4 Announces Location of its Second Connecticut Lab; Harbor Landing in Stamford Will Soon Be Home to 300+ Employees
Sema4, a patient-centered health intelligence company, announced the location of the company’s second laboratory space in Connecticut for its genomic testing products and digital... Read More
August 2, 2019
Precision for Medicine launches biospecimen solutions offering with acquisition of ProMedDx and GLAS
Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise... Read More
August 2, 2019
Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing
Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation... Read More
July 3, 2019
Genomenon Report Reveals Gene Fusion Data a Critical Factor in Cancer Diagnostics and Drug Development
Genomenon has released a research report detailing clinically significant fusion genes reported through April 2019. Fusion genes have long been known to play an... Read More
July 12, 2019
Precision Medicine changing how value is created and delivered in biopharmaceutical and diagnostics industries
Newsweek has released the results of a new report on precision medicine from their Vantage Thought Leadership division. The report, entitled Precision Medicine: Creating... Read More
July 12, 2019
GNS Healthcare Raises $23 Million Led by Cigna Ventures
GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate... Read More
July 12, 2019
Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment
Agilent Technologies Inc. (NYSE: A) has announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax... Read More
July 12, 2019
Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies
–Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Tmunity Therapeutics, Inc., a private clinical-stage... Read More
July 12, 2019
AmerisourceBergen Announces Long-Term Strategic Relationship with OneOncology
VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen, a global healthcare solutions leader, today announced that it has entered a long-term strategic relationship with OneOncology, the national partnership... Read More
April 12, 2019
Tumor Mutation Burden Study Shows Viability of In-House Testing
As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden... Read More
April 12, 2019
Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360
Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health... Read More
April 12, 2019
SomaLogic announces new collaboration with Janssen Research & Development
SomaLogic, Inc. has announced that it has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies... Read More
April 12, 2019
FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia
The FH Foundation recently announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal... Read More
April 12, 2019
SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection
SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight... Read More
April 3, 2019
PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management
Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world, launched GenePrism: Actionable Insights, a new genetic... Read More
April 3, 2019
Pat Basu, MD, MBA, named President and Chief Executive Officer of Cancer Treatment Centers of America
BOCA RATON, Fla., April 3, 2019 /PRNewswire/ — Pat A. Basu, MD, MBA, an accomplished health care executive and entrepreneur, has been appointed President... Read More
April 3, 2019
Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer
• CE-IVD marked software as a medical device that aids clinicians to more easily interpret NGS oncology tests • Classifies detected variants in accordance... Read More
April 2, 2019
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing
WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer... Read More
Tweets
New post: CHI Franciscan Activates First AI-Powered Hospital Mission Control Center in Washington State https://t.co/IYp6Eo0maC, - Niie to see The Journal of Precision Medicine taking prime placement on Mark's wall! https://t.co/mUyc8crBMW https://t.co/bZQdjEyebq,
- Only 36 hours left to register for PMLS EAST in Philadelphia - make sure you are part of the conversation with lead… https://t.co/wohM6ZEJnb,